Reduced platelet adhesion in flowing blood to fibrinogen by alterations in segment γ316–322, part of the fibrin‐specific region *

Summary. The interaction of platelets with fibrinogen is a key event in the maintenance of a haemostatic response. It has been shown that the 12‐carboxy‐terminal residues of the γ‐chain of fibrinogen mediate platelet adhesion to immobilized fibrinogen. These studies, however, did not exclude the possibility that other domains of fibrinogen are involved in interactions with platelets. To obtain more insight into the involvement of other domains of fibrinogen in platelet adhesion, we studied platelet adhesion in flowing blood to patient dysfibrinogen Vlissingen/Frankfurt IV (V/FIV), to several variant recombinant fibrinogens with abnormalities in the γ‐chain segments γ318–320 and γ408–411. Perfusion studies at physiological shear rates showed that platelet adhesion was absent to γΔ408‐411, slightly reduced to the heterozygous patient dysfibrinogen V/FIV and strongly reduced to the homozygous recombinant fibrinogens: γΔ319‐320, γ318Asp→Ala and γ320Asp→Ala. Furthermore, antibodies raised against the sequences γ308–322 and γ316–333 inhibited platelet adhesion under shear conditions. These experiments indicated that the overlapping segment γ316–322 contains amino acids that could be involved in platelet adhesion to immobilized fibrinogen under flow conditions. In soluble fibrinogen, this sequence is buried inside the fibrinogen molecule and becomes exposed after polymerization. In addition, we have shown that this fibrin‐specific sequence also becomes exposed when fibrinogen is immobilized on a surface.

[1]  J. Vermylen,et al.  The ATP-Gated P2X1 Ion Channel Acts as a Positive Regulator of Platelet Responses to Collagen , 2001, Thrombosis and Haemostasis.

[2]  S. Lord,et al.  Polymerization Site a Function Dependence on Structural Integrity of Its Nearby Calcium Binding Site , 2001, Annals of the New York Academy of Sciences.

[3]  J. Sixma,et al.  Absence of Fibrinogen in Afibrinogenemia Results in Large but Loosely Packed Thrombi under Flow Conditions , 2001, Thrombosis and Haemostasis.

[4]  Kelly A. Hogan,et al.  Recombinant Fibrinogen Vlissingen/Frankfurt IV , 2000, The Journal of Biological Chemistry.

[5]  S. Lord,et al.  A Functional Assay Suggests that Heterodimers Exist in Two C-Terminal γ-Chain Dysfibrinogens: Matsumoto I and Vlissingen/Frankfurt IV , 2000, Thrombosis and Haemostasis.

[6]  S. Lord,et al.  γ-Chain Dysfibrinogenemias: Molecular Structure-Function Relationships of Naturally Occurring Mutations in the γ Chain of Human Fibrinogen , 1998 .

[7]  S. Lord,et al.  The Contribution of the Three Hypothesized Integrin-Binding Sites in Fibrinogen to Platelet-Mediated Clot Retraction , 1998 .

[8]  E. Davie,et al.  Crystal structure of a 30 kDa C-terminal fragment from the γ chain of human fibrinogen , 1997 .

[9]  M. J. Danton,et al.  Impaired platelet aggregation and sustained bleeding in mice lacking the fibrinogen motif bound by integrin alpha IIb beta 3. , 1996, The EMBO journal.

[10]  S. Lord,et al.  Dissecting Clot Retraction and Platelet Aggregation , 1996, The Journal of Biological Chemistry.

[11]  Brian Savage,et al.  Initiation of Platelet Adhesion by Arrest onto Fibrinogen or Translocation on von Willebrand Factor , 1996, Cell.

[12]  Yeqing Song,et al.  A Monoclonal Antibody against a peptide sequence of Fibrinogen Gamma Chain Acts as an Inhibitor of factor XIII-Mediated Crosslinking of Human Fibrin , 1995, Thrombosis and Haemostasis.

[13]  J. Sixma,et al.  Evidence that fibrin alpha-chain RGDX sequences are not required for platelet adhesion in flowing whole blood. , 1995, Blood.

[14]  D. Farrell,et al.  Binding of recombinant fibrinogen mutants to platelets. , 1994, The Journal of biological chemistry.

[15]  N. Kirschbaum,et al.  Characterization of adhesion of resting and stimulated platelets to fibrinogen and its fragments. , 1993, Annals of the New York Academy of Sciences.

[16]  P. D. de Groot,et al.  Platelet adhesion to fibrin(ogen). , 1993, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[17]  L. Parise,et al.  Evidence for novel binding sites on the platelet glycoprotein IIb and IIIa subunits and immobilized fibrinogen. , 1993, The Biochemical journal.

[18]  S. Lord,et al.  The Residues AGDV of Recombinant γ Chains of Human Fibrinogen Must Be Carboxy-Terminal to Support Human Platelet Aggregation , 1992, Thrombosis and Haemostasis.

[19]  E. Davie,et al.  Role of fibrinogen alpha and gamma chain sites in platelet aggregation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Lord,et al.  A congenitally abnormal fibrinogen (Vlissingen) with a 6-base deletion in the gamma-chain gene, causing defective calcium binding and impaired fibrin polymerization. , 1991, The Journal of biological chemistry.

[21]  W. Nieuwenhuizen,et al.  The sequence gamma-(312-324) is a fibrin-specific epitope. , 1991, Blood.

[22]  David R. Phillips,et al.  GPIIb-IIIa: The responsive integrin , 1991, Cell.

[23]  S. Chou,et al.  Fibrin(ogen) peptide B beta 15-42 inhibits platelet aggregation and fibrinogen binding to activated platelets. , 1988, Biochemistry.

[24]  E Ruoslahti,et al.  New perspectives in cell adhesion: RGD and integrins. , 1987, Science.

[25]  J. Sixma,et al.  Subendothelial Proteins and Platelet Adhesion: von Willebrand Factor and Fibronectin, Not Thrombospondin, Are involved in Platelet Adhesion to Extracellular Matrix of Human Vascular Endothelial Cells , 1986, Arteriosclerosis.

[26]  J. Hermans,et al.  Characterization of soluble polymerized fibrin formed in the presence of excess fibrinogen fragment D. , 1984, Biochemistry.

[27]  S. Timmons,et al.  Platelet receptor recognition site on human fibrinogen. Synthesis and structure-function relationship of peptides corresponding to the carboxy-terminal segment of the gamma chain. , 1984, Biochemistry.

[28]  S. Timmons,et al.  Localization of a site interacting with human platelet receptor on carboxy-terminal segment of human fibrinogen gamma chain. , 1982, Biochemical and biophysical research communications.

[29]  T. Edgington,et al.  Interaction of fibrinogen with its platelet receptor as part of a multistep reaction in ADP-induced platelet aggregation. , 1980, The Journal of biological chemistry.

[30]  R. Colman,et al.  Thrombosis and Haemostasis , 1988 .

[31]  G. Vilaire,et al.  Exposure of platelet fibrinogen receptors by ADP and epinephrine. , 1979, The Journal of clinical investigation.

[32]  R. Doolittle,et al.  The amino acid sequence of the α-chain of human fibrinogen , 1979, Nature.

[33]  S. Sherry,et al.  The preparation and properties of human fibrinogen of relatively high solubility. , 1966, Biochemistry.

[34]  P. D. de Groot,et al.  The contribution of the three hypothesized integrin-binding sites in fibrinogen to platelet-mediated clot retraction. , 1998, Blood.

[35]  E. Davie,et al.  Crystal structure of a 30 kDa C-terminal fragment from the gamma chain of human fibrinogen. , 1997, Structure.

[36]  L. McIntire,et al.  Adhesion of platelets to surface-bound fibrinogen under flow. , 1996, Blood.

[37]  R. Doolittle,et al.  The amino acid sequence of the alpha-chain of human fibrinogen. , 1979, Nature.

[38]  Alan G. Marshall,et al.  Biophysical Chemistry: Principles, Techniques and Applications , 1978 .

[39]  Tomislav Barth,et al.  PREPARATION AND PROPERTIES , 1975 .

[40]  W. Wooster,et al.  Crystal structure of , 2005 .

[41]  R. Hill,et al.  The subunit polypeptides of human fibrinogen. , 1966, Archives of biochemistry and biophysics.